# Teru Hideshima

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/teru-hideshima/

## Facts

| Field | Value |
| --- | --- |
| Citations | 54,225 |
| Field | Multiple Myeloma Research and Treatments |
| h-index | 122 |
| i10-index | 358 |
| Last Known Institution | Harvard University |
| OpenAlex ID | https://openalex.org/A5091207345 |
| ORCID iD | https://orcid.org/0000-0003-2939-6224 |
| Works | 1,057 |

## Researcher papers

- [Lenalidomide, bortezomib, and dexamethasone combination therapy in patients with newly diagnosed multiple myeloma](https://scholariq.org/papers/lenalidomide-bortezomib-and-dexamethasone-combination-therapy-in-patients-with/)
- [Immunomodulatory drug CC-5013 overcomes drug resistance and is well tolerated in patients with relapsed multiple myeloma](https://scholariq.org/papers/immunomodulatory-drug-cc-5013-overcomes-drug-resistance-and-is-well-tolerated-in/)
- [A randomized phase 2 study of lenalidomide therapy for patients with relapsed or relapsed and refractory multiple myeloma](https://scholariq.org/papers/a-randomized-phase-2-study-of-lenalidomide-therapy-for-patients-with-relapsed-or/)
- [Anti-CS1 humanized monoclonal antibody HuLuc63 inhibits myeloma cell adhesion and induces antibody-dependent cellular cytotoxicity in the bone marrow milieu](https://scholariq.org/papers/anti-cs1-humanized-monoclonal-antibody-huluc63-inhibits-myeloma-cell-adhesion/)
- [Bortezomib induces canonical nuclear factor-κB activation in multiple myeloma cells](https://scholariq.org/papers/bortezomib-induces-canonical-nuclear-factor-b-activation-in-multiple-myeloma/)
- [A novel Aurora-A kinase inhibitor MLN8237 induces cytotoxicity and cell-cycle arrest in multiple myeloma](https://scholariq.org/papers/a-novel-aurora-a-kinase-inhibitor-mln8237-induces-cytotoxicity-and-cell-cycle/)

## Researcher topics

- [Multiple Myeloma Research and Treatments](https://scholariq.org/topics/multiple-myeloma-research-and-treatments/)
- [Protein Degradation and Inhibitors](https://scholariq.org/topics/protein-degradation-and-inhibitors/)
- [Peptidase Inhibition and Analysis](https://scholariq.org/topics/peptidase-inhibition-and-analysis/)
- [Ubiquitin and proteasome pathways](https://scholariq.org/topics/ubiquitin-and-proteasome-pathways-2/)
- [Histone Deacetylase Inhibitors Research](https://scholariq.org/topics/histone-deacetylase-inhibitors-research/)

## Researcher university

- [Harvard University](https://scholariq.org/institutions/harvard-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.